Results 131 to 140 of about 1,499 (169)

Role of HMGB1 (High Mobility Group Box-1) in malignant mesothelioma pathogenesis, prognosis and as predictive biomaker. [PDF]

, 2018
Rrapaj, Eltjona
core   +1 more source

Diaforesis recurrente, estado confusional agudo y mesotelioma pleural

Neurología, 2017
Domínguez, R.O., Cárdenas, E.M., Marulanda, Y.H.S., Bartolomé, E.L.   +3 more
openaire   +1 more source

Quercetin and Cisplatin combined treatment altered cell cycle and mitogen activated protein kinase expressions in malignant mesotelioma cells. [PDF]

BMC Complement Altern Med, 2016
Demiroglu-Zergeroglu A, Ergene E, Ayvali N, Kuete V, Sivas H.   +4 more
europepmc   +1 more source

Pressurised Intraperitoneal Aerosolised Chemotherapy-Results from the First Hundred Consecutive Procedures. [PDF]

Cancers (Basel)
Hoskovec D, Krška Z, Vočka M, Argalácsová S, Dytrych P.   +4 more
europepmc   +1 more source

The Oncolytic Virus dl922-947 Triggers Immunogenic Cell Death in Mesothelioma and Reduces Xenograft Growth. [PDF]

Front Oncol, 2019
Di Somma S, Iannuzzi CA, Passaro C, Forte IM, Iannone R, Gigantino V, Indovina P, Botti G, Giordano A, Formisano P, Portella G, Malfitano AM, Pentimalli F.   +12 more
europepmc   +1 more source

Cholangiocarcinoma and Occupational Exposure to Asbestos: Insights From the Italian Pooled Cohort Study. [PDF]

Med Lav
Curti S, Gallo M, Ferrante D, Bella F, Boschetti L, Casotto V, Ceppi M, Cervino D, Fazzo L, Fedeli U, Giorgi Rossi P, Giovannetti L, Girardi P, Lando C, Migliore E, Miligi L, Oddone E, Perlangeli V, Pernetti R, Piro S, Storchi C, Tumino R, Zona A, Zorzi M, Brandi G, Ferretti S, Magnani C, Marinaccio A, Mattioli S.   +28 more
europepmc   +1 more source

Asbestos exposure and malignant mesothelioma of the tunica vaginalis testis: a systematic review and the experience of the Apulia (southern Italy) mesothelioma register. [PDF]

Environ Health, 2019
Vimercati L, Cavone D, Delfino MC, De Maria L, Caputi A, Ferri GM, Serio G.   +6 more
europepmc   +1 more source

'Cell knife' for cancer: the clinician's perspective. [PDF]

Front Immunol
Zhou Z, Chen Y, Wang Y, Hong Y, Guan H, Huang F, Fu F, Li X, Zheng R, Xu B.   +9 more
europepmc   +1 more source